EX-23.1 3 cccc-ex231_10.htm EX-23.1 cccc-ex231_10.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (No. 333-260972, No. 333-249286, and No. 333-254145) on Forms S-3 and S-8 of our reports dated February 24, 2022, with respect to the consolidated financial statements of C4 Therapeutics, Inc. and the effectiveness of internal control over financial reporting.

 

/s/ KPMG LLP

Boston, Massachusetts
February 24, 2022